ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,080.13
0.21%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Black Diamond Therapeutics Inc (BDTX)

  7. Black Diamond Therapeutics Inc (BDTX) Noticias

BDTX

Black Diamond Therapeutics (BDTX)

Black Diamond Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BDTX
FechaHoraFuenteTítuloSímboloCompañía
13/05/202418:09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202406:30GlobeNewswire Inc.Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202406:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
24/04/202415:05GlobeNewswire Inc.Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/04/202407:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Changes to Board of DirectorsNASDAQ:BDTXBlack Diamond Therapeutics Inc
07/04/202417:00GlobeNewswire Inc.Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
03/04/202407:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
12/03/202407:00GlobeNewswire Inc.Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/03/202412:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
05/03/202415:30GlobeNewswire Inc.Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024NASDAQ:BDTXBlack Diamond Therapeutics Inc
28/02/202407:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202416:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
14/02/202409:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/01/202407:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Corporate Update and Expected 2024 MilestonesNASDAQ:BDTXBlack Diamond Therapeutics Inc
13/12/202306:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBMNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202306:45GlobeNewswire Inc.Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
14/10/202311:30GlobeNewswire Inc.Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535NASDAQ:BDTXBlack Diamond Therapeutics Inc
04/10/202311:14GlobeNewswire Inc.Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:BDTXBlack Diamond Therapeutics Inc
18/09/202306:00GlobeNewswire Inc.Black Diamond Therapeutics Announces CEO TransitionNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/09/202307:00GlobeNewswire Inc.Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung CancerNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/08/202306:30GlobeNewswire Inc.Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
30/06/202315:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
29/06/202319:57GlobeNewswire Inc.Black Diamond Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:BDTXBlack Diamond Therapeutics Inc
29/06/202305:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BDTXBlack Diamond Therapeutics Inc
28/06/202315:23GlobeNewswire Inc.Black Diamond Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:BDTXBlack Diamond Therapeutics Inc
27/06/202306:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BDTXBlack Diamond Therapeutics Inc
27/06/202306:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation FamiliesNASDAQ:BDTXBlack Diamond Therapeutics Inc
16/06/202317:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BDTXBlack Diamond Therapeutics Inc
13/06/202307:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development OfficerNASDAQ:BDTXBlack Diamond Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BDTX

Su Consulta Reciente

BOV
VRTX34Q
Vertex Pharmaceuticals
LSE
STWA
BITMOT
561598
Bund Lg40 Eur 4,75
LSE
0Y7F
Ubs(irl)etfplc-fctr Msci...
BOV
CSNAE150
CSNAE150 Ex:14,28
BOV
PPLA11M
PPLA UNT UNT
USOTC
BRBOY
Brembo (PK)
COIN
LOCCUSD
NASDAQ
IPVIU
InterPrivate IV InfraTec...
USOTC
FACCF
First Asset Cambridge Co... (GM)
ASX
XJOMOC
USOTC
NEWEN
New England Power (PK)
BINA
GXSETH
BIT
UV4M5Q
UniCredit Bank
LSE
UC79
Ubsetf Msrusa
BOV
BSTP39
Pimco Exchange Traded
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados